General form of registration statement for all companies including face-amount certificate companies
Cover
Document and Entity Information
Financial Statements
CONSOLIDATED BALANCE SHEETS (FY)
CONSOLIDATED BALANCE SHEETS (Parentheticals) (FY)
CONSOLIDATED STATEMENTS OF OPERATIONS (FY)
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (FY)
CONSOLIDATED STATEMENTS OF CASH FLOWS (FY)
Condensed Consolidated Balance Sheets (Q2)
Condensed Consolidated Balance Sheets (Q2) (Parenthetical)
Condensed Consolidated Statements of Operations (Q2)
Condensed Statements of Changes in Stockholders' Deficit (Q2)
Condensed Consolidated Statements of Cash Flows (Q2)
Notes to Financial Statements
Nature of Business and Significant Accounting Policies (FY)
Going Concern (FY)
Discontinued Operations (FY)
Investment in TruPet (FY)
Dividends Payable (FY)
Accounts Payable and Accrued Liabilities (FY)
Related Party Transactions (FY)
Derivative Liability (FY)
Convertible Notes Payable (FY)
Stockholders' Deficit (FY)
Fair Value of Financial Instruments (FY)
Income Taxes (FY)
Subsequent Events (FY)
Nature of Business and Summary of Significant Accounting Policies (Q2)
Acquisition of TruPet LLC and Bona Vida, Inc. (Q2)
Inventories (Q2)
Property and Equipment (Q2)
Operating Leases (Q2)
License Intangibles and Royalties (Q2)
Line of Credit and Debt (Q2)
Warrant Derivative Liability (Q2)
Loyalty Program Provision (Q2)
Other Liabilities (Q2)
Redeemable Preferred Stock (Q2)
Stockholders' Deficit (Q2)
Related Party Transactions and Material Service Agreements (Q2)
Major Suppliers (Q2)
Concentration of Credit Risk (Q2)
Net Loss per Share (Q2)
Going Concern (Q2)
Subsequent Events (Q2)
Accounting Policies
Accounting Policies, by Policy (Policies)
Nature of Business and Summary of Significant Accounting Policies (Q2) (Policies)
Notes Tables
Nature of Business and Significant Accounting Policies (FY) (Tables)
Discontinued Operations (FY) (Tables)
Accounts Payable and Accrued Liabilities (FY) (Tables)
Derivative Liability (FY) (Tables)
Convertible Notes Payable (FY) (Tables)
Stockholders' Deficit (FY) (Tables)
Fair Value of Financial Instruments (FY) (Tables)
Income Taxes (FY) (Tables)
Nature of Business and Summary of Significant Accounting Policies (Q2) (Tables)
Acquisition of TruPet LLC and Bona Vida, Inc. (Q2) (Tables)
Inventories (Q2) (Tables)
Property and Equipment (Q2) (Tables)
Operating Leases (Q2) (Tables)
License Intangibles and Royalties (Q2) (Tables)
Warrant Derivative Liability (Q2) (Tables)
Other Liabilities (Q2) (Tables)
Redeemable Preferred Stock (Q2) (Tables)
Stockholders' Deficit (Q2) (Tables)
Net Loss per Share (Q2) (Tables)
Notes Details
Nature of Business and Significant Accounting Policies (FY) (Details)
Nature of Business and Significant Accounting Policies - Antidilutive Securities Excluded from Computation of Earnings Per Share (FY) (Details)
Going Concern (FY) (Details)
Discontinued Operations (FY) (Details)
Discontinued Operations - After-Tax Loss from Discontinued Operations (FY) (Details)
Discontinued Operations - Gain on Sale of Discontinued Operations (FY) (Details)
Investment in TruPet (FY) (Details)
Dividends Payable (FY) (Details)
Accounts Payable and Accrued Liabilities - Accounts Payable and Accrued Liabilities (FY) (Details)
Related Party Transactions (FY) (Details)
Derivative Liability (FY) (Details)
Derivative Liability - Fair Value, Derivative Liability Measured on Recurring Basis, Unobservable Input Reconciliation (FY) (Details)
Derivative Liability - Fair Value Measurements, Recurring, Valuation Techniques (FY) (Details)
Convertible Notes Payable (FY) (Details)
Convertible Notes Payable - Convertible Debt (FY) (Details)
Convertible Notes Payable - Convertible Debt (Parentheticals) (FY) (Details)
Stockholders' Deficit (FY) (Details)
Stockholders' Deficit - Warrants or Rights Shares Authorized, by Exercise Price Range (FY) (Details)
Stockholders' Deficit - Stockholders' Equity Note, Warrants or Rights (FY) (Details)
Stockholders' Deficit - Share-based Compensation, Shares Authorized under Stock Option Plans (FY) (Details)
Stockholders' Deficit - Share-based Compensation, Stock Options, Activity (FY) (Details)
Fair Value of Financial Instruments - Fair Value, Liabilities Measured on Recurring Basis (FY) (Details)
Income Taxes (FY) (Details)
Income Taxes - Effective Income Tax Rate Reconciliation (FY) (Details)
Income Taxes - Deferred Tax Assets and Liabilities (FY) (Details)
Subsequent Events (FY) (Details)
Nature of Business and Summary of Significant Accounting Policies, Restricted Cash (Q2) (Details)
Nature of Business and Summary of Significant Accounting Policies, Property and Equipment (Q2) (Details)
Nature of Business and Summary of Significant Accounting Policies, Income Taxes (Q2) (Details)
Nature of Business and Summary of Significant Accounting Policies, Revenue (Q2) (Details)
Nature of Business and Summary of Significant Accounting Policies, Advertising, Research and Development (Q2) (Details)
Nature of Business and Summary of Significant Accounting Policies, Shipping and Handling/Freight Out (Q2) (Details)
Nature of Business and Summary of Significant Accounting Policies, Segment Information (Q2) (Details)
Nature of Business and Summary of Significant Accounting Policies, Recently Issued Accounting Pronouncements (Q2) (Details)
Acquisition of TruPet LLC and Bona Vida, Inc. (Q2) (Details)
Inventories (Q2) (Details)
Property and Equipment (Q2) (Details)
Operating Leases (Q2) (Details)
License Intangibles and Royalties, Elvis Presley Enterprises, LLC (Q2) (Details)
License Intangibles and Royalties, Orapup (Q2) (Details)
Line of Credit and Debt (Q2) (Details)
Warrant Derivative Liability, Private Placement (Q2) (Details)
Warrant Derivative Liability, Fair Value of Derivative Liabilities (Q2) (Details)
Warrant Derivative Liability, Fair Value Measurements and Valuation Techniques (Q2) (Details)
Loyalty Program Provision (Q2) (Details)
Other Liabilities (Q2) (Details)
Redeemable Preferred Stock (Q2) (Details)
Stockholders' Deficit (Q2) (Details)
Stockholders' Deficit, Preferred Units/Stock (Q2) (Details)
Stockholders' Deficit, Common Stock (Q2) (Details)
Stockholders' Deficit, Stock Options (Q2) (Details)
Stockholders' Deficit, Option Grants (Q2) (Details)
Stockholders' Deficit, Significant Terms of Options Outstanding (Q2) (Details)
Stockholders' Deficit, Transactions Involving Options (Q2) (Details)
Stockholders' Deficit, Warrants (Q2) (Details)
Related Party Transactions and Material Service Agreements, Related Party Transactions (Q2) (Details)
Related Party Transactions and Material Service Agreements, Material Service Agreements (Q2) (Details)
Major Suppliers (Q2) (Details)
Concentration of Credit Risk (Q2) (Details)
Net Loss per Share (Q2) (Details)
Going Concern (Q2) (Details)
Subsequent Events (Q2) (Details)
Other Liabilities (Q2) (Tables)
v3.19.3
Other Liabilities (Q2) (Tables)
6 Months Ended
Jun. 30, 2019
Other Liabilities [Abstract]
Other Liabilities
Dollars in thousands
Advance #1
Advance #2
Advance #3
Total
Opening balance – January 1, 2018
$
-
$
-
$
-
$
-
Advance of outstanding amounts
399
965
1,050
2,414
2018 Payments
(429
)
(256
)
(102
)
(787
)
Rollover to Advance #3
(824
)
824
Advance fixed fee
30
115
126
271
Closing Balance – December 31, 2018
-
-
1,899
1,899
Payments
(1,899
)
(1,899
)
Balance June 30, 2019
$
-
$
-
$
-
$
-
X
- References
No definition available.
+ Details
Name:
us-gaap_OtherLiabilitiesDisclosureAbstract
Namespace Prefix:
us-gaap_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Tabular disclosure of other liabilities.
+ References
No definition available.
+ Details
Name:
us-gaap_OtherLiabilitiesTableTextBlock
Namespace Prefix:
us-gaap_
Data Type:
nonnum:textBlockItemType
Balance Type:
na
Period Type:
duration